Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>Claire Wainwright, Michael Boyle, K. De Boeck et al.|New England Journal of Medicine|2015Cited by 1.6k
The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public–private partnerships for the development of new strategies to tackle antibiotic resistanceTomislav Kostyanev, Herman Goossens, Marc J. M. Bonten et al.|Journal of Antimicrobial Chemotherapy|2015Cited by 129
Interventions for enhancing adherence to treatment in adults with bronchiectasisAmanda McCullough, Carmel Hughes, Elizabeth T Thomas et al.|Cochrane Database of Systematic Reviews|2015Cited by 15
P139 Microbial community composition and patient reported symptoms in cystic fibrosisKatherine O’Neill, Michael M. Tunney, G.G. Einarsson et al.|Journal of Cystic Fibrosis|2019Cited by 0